MCP Waters-The Science of What's Possible
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Glossary
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bergeron, J.
Right arrow Articles by Walsh, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bergeron, J.
Right arrow Articles by Walsh, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Molecular & Cellular Proteomics 2:368, 2003.
© 2003 by The American Society for Biochemistry and Molecular Biology, Inc.


ANNOUNCEMENT

IUBMB and HUPO Congresses Combine

John Bergeron, Chair

Scientific Program Committee, HUPO World Congress in Proteomics 2003

Mike Walsh, Chair

Scientific Program Committee, IUBMB Congress 2003

A combination of SARS, heightened tensions regarding security, and a general reluctance to travel have recently dealt a devastating blow to major scientific meetings in Toronto. In this light, the decision to combine the previously cancelled International Union of Biochemistry & Molecular Biology (IUBMB) Congress (the principal international conference for biochemistry and molecular biology) with the Human Proteome Organization (HUPO) World Congress in Montreal (October 8–11) comes as a welcome solution. Following the highly successful American Society for Mass Spectrometry (ASMS) meeting in Montreal in June (the largest international meeting for mass spectrometry and the application of this technology to proteomics), the combined HUPO-IUBMB meeting in October will serve as a showcase not only for the most recent international advances in molecular biology and biochemistry but also to define the vision and immediate goals of proteomics. Proteomics is challenged with using high-throughput methodologies to characterize proteins and their interactions in as reliable and comprehensive a manner as DNA sequencing was used in the successful elucidation of the human and other genomes. Due in large part to revolutionary technological developments, excitement and enthusiasm are currently growing for proteomics and its applications via HUPO programs; however, the ability to gather funding and execute large-scale projects are still in the nascent stage. These efforts are certainly dependent on their potential application to solving problems in biology and medicine. The unanticipated merger of the IUBMB and HUPO Congresses provides an opportunity to exploit the synergism of biochemistry and molecular biology with proteomics and provide a new intellectual sustenance to help HUPO and its programs to deliver on the unbounded promises of proteomics. Thus the participants attracted to the two meetings will have an unprecedented opportunity to exchange ideas and results that should invigorate both disciplines, particularly in overlapping areas such as signal transduction. Importantly, main themes of the HUPO Congress, such as several large-scale proteomics initiatives that will be critically assessed for their feasibility, funding, and deliverables, will remain highlights. There is no foreseeable end to the proteomics era, and this combined IUBMB and HUPO Congress in Montreal in October is likely a preview of how proteomics meetings will be conducted in the future. It may well represent a defining transition in the development of the proteomics field.

FOOTNOTES

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Glossary
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bergeron, J.
Right arrow Articles by Walsh, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bergeron, J.
Right arrow Articles by Walsh, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Journal of Lipid Research   ASBMB Today